RWMG
DNA icon

Redwood Wealth Management Group’s Ginkgo Bioworks DNA Stock Holding History

Redwood Wealth Management Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,720
Closed -$23K – 403
2024
Q2 		$23K Buy
+1,720
New +$51.3K 0.02% 425
2024
Q1 		– Sell
-1,501
Closed -$101K – 121
2023
Q4 		$101K Sell
1,501
-211
-12% -$12.9K 0.11% 123
2023
Q3 		$124K Buy
1,712
+8
+0.5% +$640 0.14% 120
2023
Q2 		$127K Hold
1,704
– – 0.14% 126
2023
Q1 		$90.7K Buy
1,704
+190
+13% +$12K 0.1% 138
2022
Q4 		$102K Buy
+1,514
New +$139K 0.13% 123

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Redwood Wealth Management Group's DNA Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 1,720 shares — an estimated $23K sold.

Redwood Wealth Management Group first reported a position in DNA in Q4 2022 and held it in 6 quarters. The position peaked at $127K in Q2 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 1,720 Ginkgo Bioworks shares in Q3 2024, an estimated $23K.
  • Redwood Wealth Management Group first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 6 quarters.
  • Redwood Wealth Management Group's Ginkgo Bioworks position peaked at $127K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.